GMED Stock Recent News
GMED LATEST HEADLINES
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Investors interested in Medical - Instruments stocks are likely familiar with Globus Medical (GMED) and Penumbra (PEN). But which of these two stocks presents investors with the better value opportunity right now?
Globus Medical (GMED) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Globus Medical (GMED) delivers massive sales and earnings growth in the first quarter of 2024.
Globus Medical, Inc. (NYSE:GMED ) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Brian Kearns - Senior Vice President, Business Development and Investor Relations Daniel Scavilla - President and Chief Executive Officer Keith Pfeil - Chief Operating Officer and Chief Financial Officer Conference Call Participants Matt Blackman - Stifel Matt Taylor - Jefferies Ryan Zimmerman - BTIG Steve Lichtman - Oppenheimer & Company Craig Bijou - Bank of America Securities Caitlin Cronin - Canaccord Genuity Ravi Mishra - Truist Securities Operator Thank you for standing by. Welcome to the Globus Medical First Quarter 2024 Earnings Call.
The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Globus Medical (GMED) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.53 per share a year ago.
Evaluate the expected performance of Globus Medical (GMED) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Investors with an interest in Medical - Instruments stocks have likely encountered both Globus Medical (GMED) and Penumbra (PEN). But which of these two companies is the best option for those looking for undervalued stocks?